乳房切除后即刻重建并辅助放疗的长期并发症评估
共134例符合条件,中位随访77.4个月,主要并发症总发生率为44%,首次主要并发症平均在放疗开始后13.5个月出现,多数集中在放疗后2年内。组织扩张器/假体重建与自体组织重建后的主要并发症发生率差异无统计学意义(47.3% vs 30.4%,P = .168)。
要点
- 主要并发症总发生率为44%,6.7%的患者因并发症无法保留重建乳房。
- 首次主要并发症平均出现于放疗开始后13.5个月,68.3%在1年内、81.7%在2年内。
- 即刻自体组织重建后放疗的主要并发症发生率与假体重建相比差异无统计学意义(P = .168)。
核心结论
- 即刻重建乳房接受乳房切除后放疗(PMRT)时,首次主要并发症与重建乳房丧失的风险在放疗开始后1年内最高,随时间显著下降。
- 即刻自体组织重建后行PMRT的并发症发生率处于可接受范围。
研究设计与样本
- 共134例符合纳入标准,全部患者中位随访77.4个月(范围6–185个月)。
- 主要并发症定义为需要另行独立手术的事件;变量间比较采用Fisher精确检验与Pearson χ2检验。
主要发现
- 主要并发症总体发生率为44%。
- 9例(6.7%)出现无法通过二次手术保留重建乳房的并发症。
- 从PMRT开始到首次主要并发症的平均时间为13.5个月,68.3%的首次主要并发症发生在PMRT开始后1年内,81.7%发生在2年内。
- 即刻组织扩张器/假体重建后PMRT与即刻自体组织重建后PMRT的主要并发症发生率分别为47.3%与30.4%,差异无统计学意义(P = .168)。
关键数值与推荐
- 主要并发症定义:需要另行独立手术的事件。
- 主要并发症总体发生率44%;重建乳房无法保留者占6.7%。
- 首次主要并发症平均时间13.5个月;1年内占68.3%,2年内占81.7%。
- 组织扩张器/假体重建后PMRT 47.3% vs 自体组织重建后PMRT 30.4%,P = .168。
临床怎么用
- 对即刻重建后拟行PMRT的患者,应在放疗开始后1年内重点监测重建乳房并发症。
- 向患者交代主要并发症多集中在放疗后2年内、总体发生率约44%的风险信息。
- 即刻自体组织重建后行PMRT可作为并发症发生率合理的重建选择。
局限性
- 回顾性单中心病历 review,样本量134例,随访时间范围跨度大(6–185个月)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The purpose of this article is to report the long-term rate and timing of complications associated with postmastectomy radiation therapy (PMRT) following immediate breast reconstruction in a large patient population. METHODS AND MATERIALS: We identified and reviewed the charts of all patients with stages I through IIIC breast cancer who underwent mastectomy with immediate reconstruction followed by subsequent radiation therapy between November 1997 and May 2010. We aimed to assess the rate of major complications, defined as events requiring a separate and distinct procedure. Statistical analysis between variables was evaluated using Fisher exact test and Pearson χ2 Elder et al. (2005) test. RESULTS: In total, 134 patients met inclusion criteria for having adequate long-term follow-up and documentation. The median follow-up for all patients was 77.4 months (range, 6-185 months). The overall major complication rate was found to be 44%. Nine patients (6.7%) experienced complications for which a secondary procedure could not be performed to retain a reconstructed breast. The average time between initiation of PMRT and the first major complication was 13.5 months, with 68.3% of first major complications occurring within 1 year of PMRT initiation and 81.7% within 2 years. The difference in incidence of major complications for patients undergoing immediate tissue expander/implant reconstruction followed by PMRT was not statistically different when compared with that for patients with immediate autologous tissue reconstruction followed by PMRT (47.3% vs 30.4%, P = .168). CONCLUSIONS: The risk of first major complications and reconstruction loss in patients undergoing PMRT on immediately reconstructed breasts is greatest within 1 year of beginning radiation therapy and decreases significantly with time. Immediate autologous tissue reconstruction followed by PMRT can be performed with reasonable complication rates.
引用
- Sacotte R, Fine N, Kim JY, et al. Assessing long-term complications in patients undergoing immediate postmastectomy breast reconstruction and adjuvant radiation. Pract Radiat Oncol. 2016. PMID: 28274406. doi:10.1016/j.prro.2016.10.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。